Prescriber deficit limiting access to medicinal cannabis

TGA data shows growth in medicinal cannabis approvals, but barriers to access remain  Sales of medicinal cannabis products in 2024 are on track to double the number sold in 2023, the Penington Institute reports.  The Cannabis in Australia 2024 report flagged a continued increase in the number of patient access approvals via the Therapeutic Goods